Mirum Pharmaceuticals, Inc. · Brief

Next report

3 days

Nov 3 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

5 of 8≥ implied

Feb 26 '25±8.6%▼−7.02%×0.82

May 7 '25±7.6%▲+9.75%×1.28

Aug 6 '25±11.6%▲+12.04%×1.04

Nov 4 '25±8.2%▼−1.24%×0.15

Jan 12 '26±7.1%▲+3.38%×0.47

Q1 FY26±6.9%▼−15.13%×2.21

May 6 '26±6.1%▼−6.50%×1.07

Q2 FY26±9.3%▼−11.04%×1.19

quarterimplied−20%0+20%realized×

Q2 FY26±9.3%▼−11.04%×1.19

May '26±6.1%▼−6.50%×1.07

Q1 FY26±6.9%▼−15.13%×2.21

Jan '26±7.1%▲+3.38%×0.47

Nov '25±8.2%▼−1.24%×0.15

Aug '25±11.6%▲+12.04%×1.04

2 older reports

May '25±7.6%▲+9.75%×1.28

Feb '25±8.6%▼−7.02%×0.82

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 3 report · est.

Bull2 of 4

14disclosed supplier and customer ties in SEC filingsSEC filings

327managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

7 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

3 of 8recent reports where the move came in under the options-implied rangeEarnings history

AI captions · Sep 28 '26once per report · top 2 per case

MIRM report session

No linked exposure.

Oct 21impliedImplied move: ±11.9% into Nov 3 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.